Jane Street
BIAF icon

Jane Street’s bioAffinity Technologies BIAF Stock Holding History

Jane Street’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-367
Closed -$32K – 9143
2022
Q3 		$32K Buy
+367
New +$46.3K ﹤0.01% 9068

Other funds holding BIAF

Financial Engines Advisors
Financial Engines Advisors Santa Clara, California $49.2B AUM 14.31% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street's BIAF Position: Q4 2022 in Review

Jane Street sold out of bioAffinity Technologies (BIAF) in Q4 2022, closing a stake of 367 shares — an estimated $32K sold.

Jane Street first reported a position in BIAF in Q3 2022 and held it in 1 quarter. The position peaked at $32K in Q3 2022. 4 funds tracked by Wall St. Rank hold BIAF as of Q4 2022.

  • Jane Street reported no remaining bioAffinity Technologies position as of Q4 2022 after selling out during the quarter.
  • Jane Street sold 367 bioAffinity Technologies shares in Q4 2022, an estimated $32K.
  • Jane Street first reported a position in bioAffinity Technologies in Q3 2022 and held it in 1 quarter.
  • Jane Street's bioAffinity Technologies position peaked at $32K in Q3 2022.
  • 4 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.